ArticleJournal of translational medicine2013

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.

Lana E Kandalaft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.